HER2-positive feline mammary carcinoma

被引：5
|
作者：
Marques, Claudia [1 ]
Correia, Jorge [1 ]
Ferreira, Fernando [1 ]
机构：
[1] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth, P-1300477 Lisbon, Portugal
来源：
AGING-US | 2016年 / 8卷 / 08期
关键词：
feline mammary carcinoma; HER2-positive subtype; sHER2; cancer model;
D O I：
10.18632/aging.101015
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：1574 / 1575
页数：2
相关论文
共 50 条
  • [31] Pertuzumab in HER2-positive breast cancer
    Sendur, Mehmet A. N.
    Aksoy, Sercan
    Altundag, Kadri
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1709 - 1716
  • [32] Treatment of HER2-positive breast cancer
    Figueroa-Magalhaes, Maria Cristina
    Jelovac, Danijela
    Connolly, Roisin M.
    Wolff, Antonio C.
    BREAST, 2014, 23 (02): : 128 - 136
  • [33] HER2-Positive Metastatic Colorectal Cancer
    Hannah R. Robinson
    Wells A. Messersmith
    Robert W. Lentz
    Current Treatment Options in Oncology, 2024, 25 : 585 - 604
  • [34] Margetuximab for HER2-Positive Breast Cancer
    Cuellar, Sandra
    ONCOLOGY-NEW YORK, 2021, 35 (09): : 573 - 575
  • [35] HER2-positive advanced breast cancer
    Robert, Nicholas J.
    Favret, Anne M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 21 (02) : 293 - +
  • [36] Pembrolizumab in HER2-Positive Gastric Cancer
    Janjigian, Yelena Y.
    Kawazoe, Akihito
    Bai, Yuxian
    Xu, Jianming
    Lonardi, Sara
    Metges, Jean Phillipe
    Yanez, Patricio
    Wyrwicz, Lucjan S.
    Shen, Lin
    Ostapenko, Yuriy
    Bilici, Mehmet
    Chung, Hyun Cheol
    Shitara, Kohei
    Qin, Shukui
    Van Cutsem, Eric
    Tabernero, Josep
    Luo, Suxia
    Mahave, Mauricio
    Tang, Yong
    Lowery, Maeve
    Monteiro, Maria M. F.
    Xu, Linzhi
    Shih, Chie-Schin
    Sharan, Kanu P.
    Bhagia, Pooja
    Rha, Sun Young
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [37] Lapatinib in HER2-positive breast cancer
    Nelson, Roxanne
    LANCET ONCOLOGY, 2018, 19 (01): : 22 - 22
  • [38] HER2-directed therapies beyond progression in a patient with recurrent HER2-positive mucinous ovarian carcinoma
    Chan, Jack Junjie
    Wang, Junjie
    ANNALS OF ONCOLOGY, 2023, 34 : S1464 - S1464
  • [39] Src, a potential target for overcoming trastuzumab resistance in HER2-positive breast carcinoma
    G Peiró
    F Ortiz-Martínez
    A Gallardo
    A Pérez-Balaguer
    J Sánchez-Payá
    J J Ponce
    A Tibau
    L López-Vilaro
    D Escuin
    E Adrover
    A Barnadas
    E Lerma
    British Journal of Cancer, 2014, 111 : 689 - 695
  • [40] Significance of Src Activation Status in Trastuzumab Response in HER2-Positive Breast Carcinoma
    Gallardo, A.
    Lerma, E.
    Ortiz-Martinez, F.
    Adrover, E.
    Tibau, A.
    Barnadas, A.
    Giner, D.
    Aranda, F. I.
    Gutierrez-Avino, F. J.
    Peiro, G.
    MODERN PATHOLOGY, 2012, 25 : 40A - 40A
12345